Overall Technical outlook

Price Summary

On 2026-06-03, Jubilant Pharmova Limited's stock opened at 975.05, spiked to 980.95, declined to 964.2, and closed 0.39% higher at 978.85, with 36683 shares traded.
Over the course of 52 weeks, the stock peaked at 1236.3 and hit a low of 807.65.

Technicals

Support and Resistance: The current price is 978.85, with support at 945.4 and resistance at 981.9. This range suggests that the price might move between these levels, with 945.4 offering support and 981.9 capping further gains for Jubilant Pharmova Limited.
JUBLPHARMA supportResistance 8cd33c
Support/Resistance for JUBLPHARMA


Aroon: The current state of the AROON is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
JUBLPHARMA aroon 8cd33c
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The BOLL BANDS is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
JUBLPHARMA bbands 8cd33c
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR remains in a bearish mode, setting a resistance level that could impede any upward movement. This resistance indicates that the market may continue to face bearish pressure, with limited potential for breaking higher.
JUBLPHARMA psar 8cd33c
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for JUBLPHARMA, with no strong trend emerging.
JUBLPHARMA stoch 8cd33c
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The moving averages for the 20, 50, and 100 periods are aligned in a bearish trend, reflecting ongoing downward pressure. However, the slower SMAs are beginning to lose steam, suggesting that the bearish momentum might be fading. This could indicate a potential pivot towards a bullish direction in the near future, as the market appears to be preparing for a reversal from its current trend.
JUBLPHARMA trippleSMA 8cd33c
Tripple SMA chart for Jubilant Pharmova Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.